Skip to main content
main-content

Zeitschrift

Breast Cancer Research and Treatment

Breast Cancer Research and Treatment 1/2020

Ausgabe 1/2020

Inhaltsverzeichnis ( 26 Artikel )

13.05.2020 | Review | Ausgabe 1/2020

The effect of vitamin D supplementation on the risk of breast cancer: a trial sequential meta-analysis

Liguang Zhou, Bo Chen, Lei Sheng, Andrew Turner

15.05.2020 | Preclinical study | Ausgabe 1/2020

Lipid biosignature of breast cancer tissues by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry

Catarina L. Silva, Rosa Perestrelo, Ivo Sousa-Ferreira, Filipa Capelinha, José S. Câmara, Marijana Petković

15.05.2020 | Preclinical study | Ausgabe 1/2020

TRPC1 inhibits the proliferation and migration of estrogen receptor-positive Breast cancer and gives a better prognosis by inhibiting the PI3K/AKT pathway

Li-Ying Zhang, Yong-Qu Zhang, Yun-Zhu Zeng, Jian-Ling Zhu, Huan Chen, Xiao-Long Wei, Li-Juan Liu

18.05.2020 | Preclinical study | Ausgabe 1/2020

High expression of OSR1 as a predictive biomarker for poor prognosis and lymph node metastasis in breast cancer

Yang Li, Jun Qin, Junyi Wu, Xueming Dai, Junming Xu

19.05.2020 | Preclinical study | Ausgabe 1/2020

Does sentinel lymph node biopsy for screening high-grade ductal carcinoma in situ of the breast cause more harm than good?

Saed Ramzi, Erum Najeeb, James Coulthard, Stephanie Jenkins

21.05.2020 | Preclinical study | Ausgabe 1/2020

Androgen receptor expression inversely correlates with histological grade and N stage in ER+/PgRlow male breast cancer

Cristian Scatena, Rosa Scarpitta, Lorenzo Innocenti, Mario Miccoli, Rachele Biancotti, Lucrezia Diodati, Matteo Ghilli, Antonio Giuseppe Naccarato

11.05.2020 | Clinical trial | Ausgabe 1/2020

Carboplatin plus taxanes are non-inferior to epirubicin plus cyclophosphamide followed by taxanes as adjuvant chemotherapy for early triple-negative breast cancer

Feng Du, Wenmiao Wang, Yongsheng Wang, Ming Li, Anjie Zhu, Jiayu Wang, Ruigang Cai, Fei Ma, Ying Fan, Qing Li, Pin Zhang, Vladimir Todorovic, Peng Yuan, Binghe Xu

12.05.2020 | Clinical trial | Ausgabe 1/2020

The natural history of untreated estrogen receptor-positive, Her2-negative invasive breast cancer

Kristin E. Rojas, Donna-Marie Manasseh, Mary Rojas, Andrea Mattocks, Leah Portnow, Sarah Kantharia, Natalie Zelenko, Christina Giuliano, Patrick I. Borgen

16.05.2020 | Clinical trial | Ausgabe 1/2020

ABREAST: a prospective, real-world study on the effect of nab-paclitaxel treatment on clinical outcomes and quality of life of patients with metastatic breast cancer

A. Koumarianou, P. Makrantonakis, F. Zagouri, C. Papadimitriou, A. Christopoulou, E. Samantas, C. Christodoulou, A. Psyrri, D. Bafaloukos, G. Aravantinos, P. Papakotoulas, S. Baka, C. Andreadis, A. Alexopoulos, I. Bompolaki, Κ. Kampoli, S. Liori, K. Karvounis, A. Ardavanis

16.05.2020 | Clinical trial | Ausgabe 1/2020

Prediction of pathologic complete response using image-guided biopsy after neoadjuvant chemotherapy in breast cancer patients selected based on MRI findings: a prospective feasibility trial

Han-Byoel Lee, Wonshik Han, Soo-Yeon Kim, Nariya Cho, Kyoung-Eun Kim, Jung Hyun Park, Young Wook Ju, Eun-Shin Lee, Sung-Joon Lim, Jung Ho Kim, Han Suk Ryu, Dae-Won Lee, Miso Kim, Tae-Yong Kim, Kyung-Hun Lee, Sung Ui Shin, Su Hyun Lee, Jung Min Chang, Hyeong-Gon Moon, Seock-Ah Im, Woo Kyung Moon, In-Ae Park, Dong-Young Noh

19.05.2020 | Clinical trial | Ausgabe 1/2020 Open Access

Patients’ perceptions of 70-gene signature testing: commonly changing the initial inclination to undergo or forego chemotherapy and reducing decisional conflict

Julia E. C. van Steenhoven, Bianca M. den Dekker, Anne Kuijer, Paul J. van Diest, Peter Nieboer, Johanna M. Zuetenhorst, Alex L. Th. Imholz, Sabine Siesling, Thijs van Dalen

19.05.2020 | Clinical Trial | Ausgabe 1/2020

Breast-conserving surgery without axillary lymph node surgery or radiotherapy is safe for HER2-positive and triple negative breast cancer patients over 70 years of age

Ying Zhong, Yali Xu, Yidong Zhou, Feng Mao, Yan Lin, Jinghong Guan, Songjie Shen, Bo Pan, Changjun Wang, Li Peng, Xin Huang, Yan Li, Xuefei Wang, Qiang Sun

20.05.2020 | Clinical trial | Ausgabe 1/2020 Open Access

HER2-targeted therapy influences CTC status in metastatic breast cancer

Thomas M. Deutsch, Sabine Riethdorf, Carlo Fremd, Manuel Feisst, Juliane Nees, Chiara Fischer, Andreas D. Hartkopf, Klaus Pantel, Andreas Trumpp, Florian Schütz, Andreas Schneeweiss, Markus Wallwiener

20.05.2020 | Clinical trial | Ausgabe 1/2020 Open Access

EndoPredict® in early hormone receptor-positive, HER2-negative breast cancer

K. Almstedt, S. Mendoza, M. Otto, M. J. Battista, J. Steetskamp, A. S. Heimes, S. Krajnak, A. Poplawski, A. Gerhold-Ay, A. Hasenburg, C. Denkert, M. Schmidt

08.05.2020 | Epidemiology | Ausgabe 1/2020

Association of CYP19A1 gene variations with adjuvant letrozole-induced adverse events in South Indian postmenopausal breast cancer cohort expressing hormone-receptor positivity

Gurusamy Umamaheswaran, Dharanipragada Kadambari, Suresh Kumar Muthuvel, Sekar Kalaivani, Jaganathan Devi, Solai Elango Damodaran, Suresh Chandra Pradhan, Biswajit Dubashi, Steven Aibor Dkhar, Chandrasekaran Adithan

08.05.2020 | Epidemiology | Ausgabe 1/2020

The impact of ductal carcinoma in situ on health services utilization

Lawrence Paszat, Rinku Sutradhar, Eileen Rakovitch

11.05.2020 | Epidemiology | Ausgabe 1/2020

Association between the polymorphisms in MMP-2 and MMP-9 with adiposity and mammographic features

Suélène Georgina Dofara, Sue-Ling Chang, Caroline Diorio

11.05.2020 | Epidemiology | Ausgabe 1/2020

Racial/ethnic differences in supplemental imaging for breast cancer screening in women with dense breasts

Charlotte Ezratty, Suzanne Vang, Jordonna Brown, Laurie R. Margolies, Lina Jandorf, Jenny J. Lin

12.05.2020 | Epidemiology | Ausgabe 1/2020

Physical activity among patients with breast cancer receiving aromatase inhibitors is associated with bone health: a cross-sectional observational study

Takashi Saito, Rei Ono, Seishi Kono, Mika Asano, Akimasa Fukuta, Yuko Tanaka, Shintaro Takao, Yoshitada Sakai

15.05.2020 | Epidemiology | Ausgabe 1/2020

Long-term excess body fat in adulthood and the risk of pre- and postmenopausal breast cancer in Chinese women

Yu Hao, Bin Xu, Qiming Yan, Min Zhou, Can Hou, Lin Wu, Xiaorong Zhong, Jiayuan Li

18.05.2020 | Epidemiology | Ausgabe 1/2020

Association between thyroid gland diseases and breast cancer: a case–control study

Laura Bach, Karel Kostev, Leif Schiffmann, Matthias Kalder

20.05.2020 | Epidemiology | Ausgabe 1/2020 Open Access

Exploring the effects of lifestyle on breast cancer risk, age at diagnosis, and survival: the EBBA-Life study

Trygve Lofterød, Hanne Frydenberg, Vidar Flote, Anne Elise Eggen, Anne McTiernan, Elin S. Mortensen, Lars A. Akslen, Jon B. Reitan, Tom Wilsgaard, Inger Thune

21.05.2020 | Epidemiology | Ausgabe 1/2020

Synchronous bilateral breast cancer: a nationwide study on histopathology and etiology

Mathias Kvist Mejdahl, Jan Wohlfahrt, Marianne Holm, Ann Søegaard Knoop, Anne Tjønneland, Mads Melbye, Niels Kroman, Eva Balslev

14.05.2020 | Letter to the Editor | Ausgabe 1/2020

Characteristics and outcomes of patients with breast cancer diagnosed with SARS-Cov-2 infection at an academic center in New York City

Kevin Kalinsky, Melissa K. Accordino, Kristina Hosi, Jessica E. Hawley, Meghna S. Trivedi, Katherine D. Crew, Dawn L. Hershman

20.05.2020 | COVID-19 | Letter to the Editor | Ausgabe 1/2020 Open Access

Treatment options for patients with HR+/HER2− advanced breast cancer during the COVID-19 pandemic: dose reduction of ribociclib does not diminish efficacy

Joyce O’Shaughnessy

20.05.2020 | Letter to the Editor | Ausgabe 1/2020

Fertility and reproduction in breast cancer patients

Federica Tomao, Monica Verrico, Silverio Tomao

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise